Validation of Micro-Ultrasound Protocol for Anterior Prostate Cancer Risk

Overview

This multicenter retrospective study developed and validated a novel micro-ultrasound (microUS) risk score to predict clinically significant prostate cancer in the anterior prostate. The protocol demonstrated good inter-reader agreement and diagnostic accuracy in identifying anterior prostate cancer using high-resolution 29 MHz microUS imaging.

Background

Early diagnosis of prostate cancer reduces mortality and is typically achieved via ultrasound-guided biopsy. Multiparametric MRI (mpMRI) enhances detection of significant cancer but conventional ultrasound lacks sufficient tissue characterization. Micro-ultrasound at 29 MHz offers superior spatial resolution, enabling better evaluation of prostate tissue, particularly in the peripheral zone. However, prior protocols focused on the posterior prostate, leaving anterior prostate evaluation unaddressed until this study.

Data Highlights

Key Findings

• A novel microUS risk score was developed based on imaging features correlating with clinically significant anterior prostate cancer (Gleason pattern ≥4).
• Low-risk anterior prostate tissue appeared hyperechoic with smooth, contiguous capsule; high-risk tissue was hypoechoic with irregular, poorly defined margins.
• Common artifacts such as edge artifact, shadowing, and benign prostatic hyperplasia nodules were identified and accounted for in interpretation.
• Validation with 7 readers showed good sensitivity, specificity, and inter-reader agreement (Fleiss kappa and Cronbach alpha) in detecting anterior prostate cancer.
• The risk score enabled differentiation between benign and malignant anterior prostate tissue in patients undergoing biopsy or prostatectomy.

Clinical Implications

The validated microUS anterior prostate risk score provides a real-time, high-resolution imaging tool to improve detection of clinically significant anterior prostate cancer. This protocol may complement mpMRI by targeting lesions not visible on MRI and guide biopsy decisions. Incorporating microUS into clinical practice could enhance early diagnosis and reduce unnecessary biopsies.

Conclusion

This study successfully developed and validated a microUS-based risk assessment protocol for anterior prostate cancer, demonstrating its potential as a valuable adjunct to existing imaging modalities for prostate cancer detection.

References

1. Ghai et al. 2016 -- Validation of the PRI-MUS Protocol for Micro-Ultrasound
2. European Urology 2019 -- mpMRI Enhances Detection of Clinically Significant Prostate Cancer